Literature DB >> 17004916

Animal models of migraine: looking at the component parts of a complex disorder.

A Bergerot1, P R Holland, S Akerman, T Bartsch, A H Ahn, A MaassenVanDenBrink, U Reuter, C Tassorelli, J Schoenen, D D Mitsikostas, A M J M van den Maagdenberg, P J Goadsby.   

Abstract

Animal models of human disease have been extremely helpful both in advancing the understanding of brain disorders and in developing new therapeutic approaches. Models for studying headache mechanisms, particularly those directed at migraine, have been developed and exploited efficiently in the last decade, leading to better understanding of the potential mechanisms of the disorder and of the action for antimigraine treatments. Model systems employed have focused on the pain-producing cranial structures, the large vessels and dura mater, in order to provide reproducible physiological measures that could be subject to pharmacological exploration. A wide range of methods using both in vivo and in vitro approaches are now employed; these range from manipulation of the mouse genome in order to produce animals with human disease-producing mutations, through sensitive immunohistochemical methods to vascular, neurovascular and electrophysiological studies. No one model system in experimental animals can explain all the features of migraine; however, the systems available have begun to offer ways to dissect migraine's component parts to allow a better understanding of the problem and the development of new treatment strategies.

Entities:  

Mesh:

Year:  2006        PMID: 17004916     DOI: 10.1111/j.1460-9568.2006.05036.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  43 in total

Review 1.  Functional neuroimaging in migraine: usefulness for the clinical neurologist.

Authors:  Gioacchino Tedeschi; Antonio Russo; Alessandro Tessitore
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  The effect of sumatriptan on nitric oxide synthase enzyme production after iatrogenic inflammation in the brain stem of adolescent rats: A randomized, controlled, experimental study.

Authors:  Savas Demirpence; Semra Hiz Kurul; Müge Kiray; Kazim Tugyan; Osman Yilmaz; Galip Köse
Journal:  Curr Ther Res Clin Exp       Date:  2009-04

Review 3.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

4.  Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.

Authors:  Simon Akerman; Philip R Holland; Michele P Lasalandra; Peter J Goadsby
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

5.  Preliminary studies on the antinociceptive activity of Vaccinium ashei berry in experimental animal models.

Authors:  Maria Rosana Ramirez; Leandra Guterres; Odila E Dickel; Micheli R de Castro; Amelia T Henriques; Márcia M de Souza; Daniela Martí Barros
Journal:  J Med Food       Date:  2010-04       Impact factor: 2.786

Review 6.  Update on animal models of migraine.

Authors:  Marcela Romero-Reyes; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2014-11

Review 7.  Animal models of chronic migraine.

Authors:  Robin James Storer; Weera Supronsinchai; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2015-01

8.  Common variants in the regulative regions of GRIA1 and GRIA3 receptor genes are associated with migraine susceptibility.

Authors:  Daniela Formicola; Andrea Aloia; Simone Sampaolo; Olimpia Farina; Daria Diodato; Lyn R Griffiths; Fernando Gianfrancesco; Giuseppe Di Iorio; Teresa Esposito
Journal:  BMC Med Genet       Date:  2010-06-25       Impact factor: 2.103

9.  Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors.

Authors:  XiChun Zhang; Vanessa Kainz; Jun Zhao; Andrew M Strassman; Dan Levy
Journal:  Ann Neurol       Date:  2013-06-17       Impact factor: 10.422

Review 10.  Animal migraine models for drug development: status and future perspectives.

Authors:  Inger Jansen-Olesen; Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.